BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2020005)

  • 1. Altered renal fibronectin excretion in early adriamycin nephrosis of rats.
    Soose M; Gwinner W; Grotkamp J; Hansemann W; Stolte H
    J Pharmacol Exp Ther; 1991 Apr; 257(1):493-9. PubMed ID: 2020005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure to hydrocarbons and renal disease: an experimental animal model.
    Mutti A; Coccini T; Alinovi R; Toubeau G; Broeckaert F; Bergamaschi E; Mozzoni P; Nonclercq D; Bernard A; Manzo L
    Ren Fail; 1999; 21(3-4):369-85. PubMed ID: 10416216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between glomerular nephrin expression and oxidative stress reaction in rats with adriamycin-induced nephrosis].
    Zhu Y; Lu L
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):56-60. PubMed ID: 19149925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of glomerular barrier function in early adriamycin nephrosis of MWF rats.
    Soose M; Haberstroh U; Rovira-Halbach G; Brunkhorst R; Stolte H
    Clin Physiol Biochem; 1988; 6(6):310-5. PubMed ID: 3208483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Origin of urinary fibronectin.
    Gwinner W; Jäckle-Meyer I; Stolte H
    Lab Invest; 1993 Aug; 69(2):250-5. PubMed ID: 8350600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular epithelial detachment, not reduced charge density, correlates with proteinuria in adriamycin and puromycin nephrosis.
    Whiteside C; Prutis K; Cameron R; Thompson J
    Lab Invest; 1989 Dec; 61(6):650-60. PubMed ID: 2601299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
    Remuzzi G; Imberti L; Rossini M; Morelli C; Carminati C; Cattaneo GM; Bertani T
    J Clin Invest; 1985 Jan; 75(1):94-101. PubMed ID: 4038407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of oxygen radicals in adriamycin-induced nephrosis.
    Wu SH; Yang YC; Wang ZM
    Chin Med J (Engl); 1990 Apr; 103(4):283-9. PubMed ID: 2118039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of converting-enzyme inhibition and protein restriction in experimental nephrosis.
    Beukers JJ; Hoedemaeker PJ; Weening JJ
    Lab Invest; 1988 Nov; 59(5):631-40. PubMed ID: 3054313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial depletion of macrophages by ED7 reduces renal injury in Adriamycin nephropathy.
    Wang Y; Mahajan D; Tay YC; Bao S; Spicer T; Kairaitis L; Rangan GK; Harris DC
    Nephrology (Carlton); 2005 Oct; 10(5):470-7. PubMed ID: 16221097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of route administration and liposome entrapment on the metabolism and disposition of adriamycin in the rat.
    Parker RJ; Priester ER; Sieber SM
    Drug Metab Dispos; 1982; 10(5):499-504. PubMed ID: 6128200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical evaluation of the inflammatory changes in cardiac, hepatic and renal tissues of adriamycin-administered rats and the modulatory role of exogenous heparin-derivative treatment.
    Deepa PR; Varalakshmi P
    Chem Biol Interact; 2005 Oct; 156(2-3):93-100. PubMed ID: 16154121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma lipoproteins and renal apolipoproteins in rats with chronic adriamycin nephrosis.
    Joles JA; van Tol A; Jansen EH; Koomans HA; Rabelink TJ; Grond J; van Goor H
    Nephrol Dial Transplant; 1993; 8(9):831-8. PubMed ID: 8255516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin prevents adriamycin nephrotoxicity in rats.
    Venkatesan N; Punithavathi D; Arumugam V
    Br J Pharmacol; 2000 Jan; 129(2):231-4. PubMed ID: 10694226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats.
    El-Shitany NA; El-Haggar S; El-desoky K
    Food Chem Toxicol; 2008 Jul; 46(7):2422-8. PubMed ID: 18487002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial cardio-renovascular effects of a low-molecular-weight heparin-derivative on adriamycin-induced glycosaminoglycanuria and tissue lipid abnormalities.
    Deepa PR; Varalakshmi P
    Toxicology; 2005 Jul; 211(1-2):77-85. PubMed ID: 15863250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective effect of probucol on adriamycin nephrosis in the rat.
    Futenma A; Miyai H; Iida T; Hara T; Watanabe T; Shiono S; Fukatsu A; Kato K
    Nihon Jinzo Gakkai Shi; 1995 Nov; 37(11):616-21. PubMed ID: 8583697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XIII and its substrates, fibronectin, fibrinogen, and alpha 2-antiplasmin, in plasma and urine of patients with nephrosis.
    Vaziri ND; Gonzales E; Barton CH; Chen HT; Nguyen Q; Arquilla M
    J Lab Clin Med; 1991 Feb; 117(2):152-6. PubMed ID: 1993857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alteration of renal hemodynamic in adriamycin-induced nephrosis rats administrated with Wulingsan].
    He L; Cai Y; Chen ZH; Jiang JM; Wang NS
    Zhongguo Zhong Yao Za Zhi; 2006 Aug; 31(16):1358-60. PubMed ID: 17061561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Puromycin aminonucleoside and adriamycin disturb cytoskeletal and extracellular matrix protein organization, but not protein synthesis of cultured glomerular epithelial cells.
    Coers W; Huitema S; van der Horst ML; Weening JJ
    Exp Nephrol; 1994; 2(1):40-50. PubMed ID: 8081996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.